Reading the tape
NYSE: LLY
Eli Lilly and Company
Healthcare · Drug Manufacturers - General
Market Cap
$910.17B
52w High
$1,133.95
52w Low
$623.78
P/E
34.09
Volume
3.65M
Outstanding Shares
944.82M
Price vs Fundamentals
Why The Stock Is Moving
Optimism is getting priced inHigh confidence
1Y Price: 21.31%Revenue (TTM): 47.44%P/FCF: 84th pct
What changed
The stock rose 21.31% over the last year. Revenue grew 47.44% over the trailing twelve months. Operating margin moved from 41.17% to 45.87%.
What the market seems to be pricing
The stock is trading toward the richer end of its historical P/FCF range (84th percentile) while business metrics are improving. More of the upside is already embedded in the multiple now.
What would invalidate this read
Operating margin is at 45.87% — continued expansion would be needed to justify the premium. Revenue growth of 47.44% is encouraging, but any deceleration puts the stretched multiple at risk. This read changes if revenue, margins, and cash flow continue to improve faster than expected — in that case the richer multiple could still prove conservative.
Company profile
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide.
CEODavid A. Ricks
SectorHealthcare
IndustryDrug Manufacturers - General
Employees47,000
IPO dateJun 1, 1972
Valuation
Forward P/E—
EV/EBITDA35.81
Enterprise value$1T
Stock splits
Oct 16, 1997↑ Forward
Every 1 shares became 2
Dec 21, 1995↑ Forward
Every 1 shares became 2
May 1, 1989↑ Forward
Every 1 shares became 2
Jan 30, 1986↑ Forward
Every 1 shares became 2
Profitability & growth
Revenue growth55.55%
Gross margin83.51%▲3.05%vs FY2024
Operating margin45.87%▲17.26%vs FY2024
ROE77.78%▲4.23%vs FY2024
Analyst consensus
RatingBuy
Target price$1,258.47▲30.64%
33
Buy
9
Hold
3
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 6, 2026
Q3 FY26 · EPS est $8.65 · Revenue est $20.22B
View
Dividends
$6.23/shareQuarterlyDividend Aristocrat · 49yrSafeLLY pays a dividend with a 0.65% dividend yield, 49 consecutive years of growth, growing at 15.2% annually, covered 1.7× by free cash flow.
Dividend Yield
0.65%
Annual Div / Share
$6.23
5yr CAGR
+15.2%
Doubles every ~4.9yr
Payout Ratio
22.1%
Safe
Dividend Growth Rate
3yr CAGR
+15.25%
5yr CAGR
+15.2%
10yr CAGR
+11.98%
Dividend Safety
9/10Safe
Dividend History
Annualized dividend cycles per share
YearAnnual DivYoY
2025$6.23+15.4%
2024$5.40+15.1%
2023$4.69+15.2%
2022$4.07+15.3%
2021$3.53+15.0%
2020$3.07+14.8%
2019$2.67+14.7%
Income Projection
Invest
$
Growth rate:
Reinvest dividends
Today
$6/yr
$1/mo
In 5 yrs
$11/yr+76%
$1/mo
In 10 yrs
$20/yr+211%
$2/mo
| Today | In 5 yrs | In 10 yrs |
|---|---|---|
$6/yr $1/mo | $11/yr+76% $1/mo | $20/yr+211% $2/mo |
Long-range projections use a capped 12% annual growth assumption.
Yield-on-cost grows from 0.65% → 2.01% over 10yr
Analysis
Dividend Strengths
Dividend Aristocrat
LLY has raised its dividend for 49 consecutive years — qualifying as a Dividend Aristocrat, demonstrating long-term commitment to shareholder income.
Well-covered by free cash flow
The dividend is covered 1.7× by free cash flow, indicating the company generates sufficient cash to sustain and potentially grow the payout without straining its finances.
Strong dividend growth rate
The 5-year CAGR of 15.2% meaningfully outpaces inflation, compounding real income growth for long-term holders.
Risks to Watch
No strong risk signal stands out from the latest period pair.
Congressional Activity
Congress Trades in LLY
STOCK Act disclosures from senators and representatives.
Lizzie Fletcher
houseSale2026-04-08$1,001 - $15,000+23d to disclose
Gilbert Cisneros
CAhouseDemocratSale2026-03-13$1,001 - $15,000+26d to disclose
Angus King
MEsenateIndependentSaleSpouse2026-02-13$1,001 - $15,000+39d to disclose
Markwayne Mullin
OKsenatePurchaseJoint2025-12-29$15,001 - $50,000+17d to discloseAngus King
MEsenateIndependentPurchaseSpouse2025-12-29$1,001 - $15,000+27d to disclose